Menu Close

What are the side effects of angiotensin converting enzyme inhibitors?

What are the side effects of angiotensin converting enzyme inhibitors?

Side effects of ACE inhibitors may include:

  • Dry cough.
  • Increased potassium levels in the blood (hyperkalemia)
  • Fatigue.
  • Dizziness from blood pressure going too low.
  • Headaches.
  • Loss of taste.

What are the side effects of taking ramipril?

Side effects of ramipril

  • A dry, tickly cough that does not get better. Cough medicines do not usually help for coughs caused by ramipril.
  • Feeling dizzy or lightheaded, especially when you stand up or sit up quickly.
  • Headaches.
  • Diarrhoea.
  • Being sick (vomiting)
  • A mild skin rash.
  • Blurred vision.

What’s captopril used for?

Captopril is used alone or together with other medicines to treat high blood pressure (hypertension). High blood pressure adds to the workload of the heart and arteries. If it continues for a long time, the heart and arteries may not function properly.

What is the best time of day to take ACE inhibitors?

Many doctors recommend their patients take heart drugs in the morning with their breakfast, but a new study from Canada suggests that one group of drugs, angiotensin-converting enzyme (ACE) inhibitors, works best when taken at bedtime because they reduce the effect of a hormone that is most active during sleep.

Do ACE inhibitors damage kidneys?

Long-Term Use of ACE Inhibitors May Cause Kidney Damage, Study Results Suggest. New research raises concerns about the commonly prescribed medications used to treat heart failure and high blood pressure, though investigators say patients should continue to take them.

Are there any medicines that end in Sartan?

These medicines have names that end in ‘sartan’, including valsartan, irbesartan, candesartan, losartan and olmesartan. Internationally, a number of these medicines have been identified as having unacceptable levels of impurities – specifically N -nitroso compounds.

Does Sartan cause cancer?

Long-term exposure, over years, can increase an individual’s risk of developing cancer. The additional risk posed by N-nitroso compounds in sartan medicines, at the concentrations identified to date, is considered to be very low. However, such contamination is considered unacceptable for a medicine.

Does your Sartan contain N-nitroso compounds?

TGA investigation – potential contamination with N-nitroso compounds The TGA has issued information for sponsors of sartan medicine to advise that requirements are being introduced to ensure that sartan medicines do not contain N-nitroso compounds – see Information for sponsors.

What is the TGA doing about the Sartan drug shortage?

The TGA is also undertaking testing of Australian ‘sartan’ medications to determine if any further batches are affected. The effect of this issue on medicine shortages is also being closely monitored. The TGA will publish updated information as it becomes available.